Markus Bangerter

Extranodal malignant lymphoma: detection with FDG PET versus CT.

Florian Moog, Markus Bangerter, C. G. Diederichs et al. · Radiology · 1998 · 323 citations

Medicine, Nuclear Medicine, Radiology +17

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.

Florian Moog, Markus Bangerter, C. G. Diederichs et al. · Radiology · 1997 · 312 citations

Medicine, Nuclear Medicine, Radiology +15

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

Florian Moog, Markus Bangerter, J. Kotzerke et al. · Journal of Clinical Oncology · 1998 · 277 citations

Medicine, Nuclear Medicine, Oncology +17

Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count

Markus Bangerter, Theodor C. Sauer, Roman Wennauer et al. · Journal of Internal Medicine · 1999 · 277 citations · Full text

Medicine, Hematology, Pathology +10

Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease

Markus Bangerter, Florian Moog, Inga Buchmann et al. · Annals of Oncology · 1998 · 246 citations · Full text

Medicine, Nuclear Medicine, Radiology +14